Have You Discussed Biomarker Testing?
Community Member
7 months agoHas your team talked about biomarker testing like EGFR, ALK, or KRAS?
Accepted Answer
Biomarker testing is such an important topic for non-small cell lung cancer patients to discuss with their oncology team. These tests can help guide treatment decisions and identify targeted therapy options that might be most effective. It's great when care teams proactively bring up testing options like EGFR, ALK, and KRAS, as this information can really make a difference in treatment planning.
3+ patients found this helpful
Community Member
2 months agoBiomarker testing is such an important topic for non-small cell lung cancer patients to discuss with their oncology team. These tests can help guide treatment decisions and identify targeted therapy options that might be most effective. It's great when care teams proactively bring up testing options like EGFR, ALK, and KRAS, as this information can really make a difference in treatment planning.
New to the community?
Create an account to connect with others navigating cancer.
Related Questions
- Should I Wait for Clinical Study Results or Start Cancer Treatment Immediately?
- Living with a Rare Genetic Mutation: My Cancer Treatment Journey
- Welcome to the Lung Cancer Support Community
- Facing Lung Cancer: Nervous About Starting Chemotherapy
- How to Cope with Multiple Lung Cancer Diagnoses?
- Struggling with My Husband's Attitude Toward My Lung Cancer Diagnosis
- How do I find clinical trials for stage 3b NSCLC recurrence?
- What treatment options work for K-ras G13C lung cancer mutation?
© 2025 Outcomes4Me Inc. All rights reserved.